These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2319467)

  • 1. Effect of dose on nicotine's reinforcing, withdrawal-suppression and self-reported effects.
    Hughes JR; Gust SW; Keenan RM; Fenwick JW
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1175-83. PubMed ID: 2319467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dose on nicotine's withdrawal-suppressing, adverse and discriminative stimulus effects in humans.
    Huges JR; Gust SW; Keenan RM; Fenwick JW
    NIDA Res Monogr; 1989; 95():428. PubMed ID: 2701310
    [No Abstract]   [Full Text] [Related]  

  • 4. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
    Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
    Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
    Jones HE; Griffiths RR
    Psychopharmacology (Berl); 2003 Jan; 165(3):280-90. PubMed ID: 12434259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
    Rohsenow DJ; Monti PM; Hutchison KE; Swift RM; MacKinnon SV; Sirota AD; Kaplan GB
    Exp Clin Psychopharmacol; 2007 Feb; 15(1):81-92. PubMed ID: 17295587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-blind, randomized, crossover trial of the effects of a nicotine pouch on the relief of tobacco withdrawal symptoms and user satisfaction.
    Thornley S; McRobbie H; Lin RB; Bullen C; Hajek P; Laugesen M; Senior H; Whittaker R
    Nicotine Tob Res; 2009 Jun; 11(6):715-21. PubMed ID: 19454549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.
    Hurt RD; Croghan GA; Beede SD; Wolter TD; Croghan IT; Patten CA
    Arch Pediatr Adolesc Med; 2000 Jan; 154(1):31-7. PubMed ID: 10632247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
    Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
    Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
    Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
    Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking.
    Cousins MS; Stamat HM; de Wit H
    Nicotine Tob Res; 2001 May; 3(2):123-9. PubMed ID: 11403726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine patch therapy in adolescent smokers.
    Smith TA; House RF; Croghan IT; Gauvin TR; Colligan RC; Offord KP; Gomez-Dahl LC; Hurt RD
    Pediatrics; 1996 Oct; 98(4 Pt 1):659-67. PubMed ID: 8885942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
    Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
    Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokers.
    Knott VJ; Fisher DJ
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):368-81. PubMed ID: 17696684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine is more reinforcing in smokers with a past history of alcoholism than in smokers without this history.
    Hughes JR; Rose GL; Callas PW
    Alcohol Clin Exp Res; 2000 Nov; 24(11):1633-8. PubMed ID: 11104110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?
    Rezaishiraz H; Hyland A; Mahoney MC; O'Connor RJ; Cummings KM
    Nicotine Tob Res; 2007 Nov; 9(11):1139-46. PubMed ID: 17978987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of a 24-hour nicotine patch and a 16-hour nicotine patch on smoking urges and sleep.
    Aubin HJ; Luthringer R; Demazières A; Dupont C; Lagrue G
    Nicotine Tob Res; 2006 Apr; 8(2):193-201. PubMed ID: 16766412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
    Donny EC; Brasser SM; Bigelow GE; Stitzer ML; Walsh SL
    Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental determinants of the reinforcing effects of nicotine in humans.
    Hughes JR
    J Subst Abuse; 1989; 1(3):319-29. PubMed ID: 7580222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.